HOME > FIRST ON ULTRA > Solar Power is a life saver in Chhattisgarh – Survey

Solar Power is a life saver in Chhattisgarh – Survey

The solar energy revolution may be all about saving the environment, but for the Indian state of Chhattisgarh, it’s impact is more immediate, and life-saving.

According to a first-of-its-kind study conducted on primary health centers in the state, PHCs with solar backup admitted 50% more patients and conducted almost twice the number of child deliveries in a month compared to centers without a solar system.

Despite being a power surplus state, one-third of the PHCs in Chhattisgarh are either un-electrified or without regular power supply.

About 90% of PHCs reported power cuts during peak operating hours. One-third of the PHCs experienced power cuts in the evening. More than 21% of the PHCs reported damage of medical equipment due to voltage fluctuations.

The study was conducted by the Council on Energy, Environment and Water (CEEW) with funding from Oxfam India, and involved 147 PHCs, including 83 having solar photovoltaic (PV) systems, across 15 districts in Chhattisgarh.

Between 2012-2016, the Chhattisgarh State Renewable Energy Development Agency (CREDA) installed 2 kWp off-grid solar PV rooftop systems across 570 PHCs in the state.

In Chhattisgarh, 90% of the solar powered PHCs reported cost savings from using solar PV systems over diesel generators. Diesel power costs INR 24-26 per kWh while solar plus battery costs around INR 12-14 per kWh.

CEEW analysis found that a solar PV system provides 3-4 hours of backup electricity for a PHC.

Also, peak generation from solar PV systems coincides with peak load times for PHCs, 12pm – 4pm, making solar not simply an effective backup generation system but also a potential primary mode of power supply.

Higher comfort due to better lighting and running fans in the solar PHCs increased patients’ willingness to get admitted, it found.

The ability of solar powered PHCs to operate cold chain, storing vaccines and drugs, and newborn care equipment also improved significantly in Chhattisgarh.

Almost one-fourth of power-deficit PHCs in the state currently rely exclusively on solar as a backup to run cold chain equipment.

“Ensuring continuous electricity supply to cold chains at PHCs is critical, especially in rural Chhattisgarh, where the infant mortality rate (43) is higher than the average for rural India (41),” CEEW said.

Meanwhile, India is far behind on its targeted additions of rooftop solar capacity.

“Providing solar systems) to all PHCs across India could contribute to about 160 MW of the rooftop target. If solar were to be extended to cover Sub-Centres (1 kW systems) and Community Health Centres (8 kW systems), the total potential would be about 415 MW,” said the agency.

Dr Arunabha Ghosh, CEO, CEEW, said, “Scaling solar systems across PHCs is in India’s interest as it meets the targets of the National Solar Mission as well as the National Health Mission.”

Chhattisgarh, famous for its forests and hills, is one of the leaders in India in making use of solar PV technology to ensure the delivery of power even in remote areas.

“Taking a cue from CREDA, other states must also focus on creating robust operations and maintenance services for solar powered PHCs,” Ghosh added.

According to the Rural Health Statistics 2016, India has about 25,000 PHCs. Of the functional PHCs in India, 4.6% are unelectrified, affecting over 38 million rural households depending on these healthcare facilities.

Further, the District Level Household and Facility Survey – 4 (DLHS-4) data indicate that one out of every two PHCs in the country suffers from unreliable power supply or has no electricity access at all. Unreliable and poor-quality electricity supply limits diagnostic and treatment services, reduces hours of operation to daytime, and forces patients to travel a longer distance in search of better healthcare.

Follow ULTRA.news
Reliance Capital to get Rs 300 cr from IREDA for lending to renewable sector Anil Ambani Group's Reliance Capital Indian Renewable Energy Development Agency Limited (IREDA) will make available Rs 300 cr for lending to renewable energy and energy efficiency projects.IREDA is a Government of India Enterprise under the administrative control of Ministr...
Adani Enterprises to demerge and list solar business Adani Enterprises Limited said it will demerge Adani Green Energy Ltd by cancelling the shares it holds in the subsidiary and issuing new shares directly to the shareholders of the parent company.Shareholders will get 761 shares of the new company for every 1,000 shares they...
NATCO Pharma to sell multiple sclerosis drug in USA via Mylan NATCO Pharma Limited said it the US Food and Drug Administration approved the generic drug application filed by its marketing partner Mylan for injections used in the treatment of multiple sclerosis, a chronic inflammatory disease of the central nervous system.The drug, Glat...
AU Small Finance Bank to distribute Aditya Birla Health insurance AU Small Finance Bank has tied up with Aditya Birla Health Insurance to to distribute the latter's health insurance products.The bank will act as a corporate agent, it said."This tie up shall be mutually beneficial for ABHICL & AU SMALL FINANCE BANK in terms of business,...
Glenmark Pharma gets USFDA approval for Desonide skin ointment Pharma giant Glenmark Pharmaceuticals said it received final approval to sell skin oinment Desonide Lotion in the US.The ointment has annual sales of approximately $23.2 million.The medicine is used to treat eczema, dermatitis, allergies, rashes etc.Desonide reduces...
Glenmark to launch Desonide topical ointment in US Glenmark Pharmaceuticals Inc said it has got the go-ahead to launch the generic version of Perrigo's anti-inflammation ointment Desonide Ointment in the US.Desonide Ointment, 0.05% had annual sales of approximately $23.4 million for the 12 month period ending July 2017, acco...
Tata Power renewable generation up four times last year Tata Power said it generated more four times as much power from renewable sources like solar and wind in the financial year ended March, compared to the year before.This was achieved partly due to an acquisition.During the year, its renewable arm Tata Power Renewable En...
10.6% of Indians have mental disorders; country faces severe shortage About 10.6% of adults in India suffer from some sort of mental disorder, including substance abuse problems, a study by the National Institute of Mental Health and Neurosciences or NIMHANS found.The study was conducted in 12 states of India by the Bangalore-based institution....
Measles makes a comeback, especially in North India The number of people getting infected with measles, a deadly disease that causes a red rash and is spread through the air, has shown a steady increase in four adjoining states of North India, as well as Gujarat.Measles is a highly contagious infection caused by the measles vi...
India achieves only 14% of rooftop solar power target Even as India more or less sticks to the target on adding large solar farms under its ambitious Solar Mission project, the other leg of the plan -- rooftop solar -- remains woefully behind target.Under the solar mission, India is supposed to have put in 5,000 megawatt of sola...
SLOW START: India adds 8.3% of 2017 target solar capacity in three months India added only 827 megawatt of solar power generation capacity in the first three months of the current financial year, indicating a slow start to the yearly program.The addition of the first three months represents only 8.27% of the 10,000 megawatt that it is supposed to c...
Zydus Cadila gets approval for obesity drug in USA Zydus Cadila said it received the final approval from the US FDA to market obesity drug Phentermine Hydrochloride.The drug will be marketed in the form of orally disintegrating tablets in strengths of 15 mg, 30 mg, and 37.5 mg.The drug is used to treat obesity in people w...
Zydus Cadila gets USFDA approval for generic version of popular migraine drug Zydus Cadila said it received final approval from the US Food and Drug Administration to market migraine drug Eletriptan Hydrobromide in the US.The drug is currently marketed and manufactured by Pfizer Inc and sold in the US and Canada under the brand name Relpax.The two...
IREDA to sell 14 cr shares in IPO to help meet India’s renewable targets The central government has okayed the listing of India's premier renewable energy agency, IREDA, via an initial public offer.Part of IREDA co-financed 202.40 MW Wind Power Project in APThe move will help the non-banking finance company "increase its equity base which wil...
India is the first country to reuse nuclear waste on large scale – Minister A rally to popularize nuclear power in Mumbai in 2014The Department of Atomic Energy today said that India is the first country in the world where the waste produced by nuclear power plants is being used for civilian applications.Jitendra Singh, the minister of state ove...
Nearly a quarter of all food samples tested found fake or adulterated Food Adulteration and Testing in India, FY16Over one-fifth of all food samples tested in India's government labs in the last year were found to be fake or adulterated, according to numbers compiled from various state government food testing facilities by union government's d...
Lopinavir syrup for children with HIV now available across India – Govt NACO ran out of Lopinavir stock in FebruaryMinister of health and family welfare Anupriya Patel said Lopinavir syrup, the life-saving drug given to infants and toddlers with HIV has been restocked by the National Aids Control Organization."NACO has done an emergency proc...
India to add 34.5 GW of hydroelectric capacity in 10 years A hydro-power plant in Himachal PradeshIndia will set a target of adding 34.5 GW of hydro-power generation capacity in the next ten years, according to power ministry sources."The target for the 13th plan has been set at 13.31 GW and that for the 14th plan will be 21.15 ...
Can’t block imports of cheap chinese solar panels – Nirmala Seetharaman The government of India said it cannot seek to slow down imports of solar power generation equipment from China as it has to watch out for the interests of Indian consumers as much as those of Indian industrialists.Responding to questions from the opposition in Lok Sabha ...
Solar power output up 75% this year, but still only 1% of total Solar, wind in India's total power production 2016-17Production of electricity from solar power is all set to rise 75% this year, while that from wind is on track to rise 51%, according to the latest numbers available with the ministry of new and renewable resources, governm...